Buscar
Mostrando ítems 1-10 de 18
Dementia in Parkinson's disease: a Brazilian sample
(Academia Brasileira de Neurologia - ABNEURO, 2011-10-01)
To determine the prevalence of dementia associated with Parkinson's disease (PD-D) in a Brazilian sample adopting clinical and diagnostic procedures recommended by the Movement Disorders Society (MDS). Sixty-seven patients ...
Metabolic syndrome and dementia associated with Parkinson's disease: Impact of age and hypertensionSíndrome metabólica e demência associada à doença de parkinson: Impacto da idade e da hipertensão arterial
(2012-01-01)
Objective: To determine correlations between age and metabolic disorders in Parkinson's disease (PD) patients. Methods: This observational cross-sectional study included brief tests for dementia and the Mattis test. Signals ...
Delayed recall memory impairment in patients with Parkinson's disease
(Associação de Neurologia Cognitiva e do Comportamento, 2016-09-01)
ABSTRACT Age is one of the risk factors for dementia in patients with Parkinson's disease (PDD). Distinct cognitive syndromes of Parkinson's disease (PD) have been identified in previous studies. Questions about the role ...
Metabolic syndrome and dementia associated with Parkinson's disease: impact of age and hypertension
(Assoc Arquivos Neuro- Psiquiatria, 2012-02-01)
Objective: To determine correlations between age and metabolic disorders in Parkinson's disease (PD) patients. Methods: This observational cross-sectional study included brief tests for dementia and the Mattis test. Signals ...
Metabolic syndrome and dementia associated with Parkinson's disease: impact of age and hypertension
(Assoc Arquivos Neuro- Psiquiatria, 2012-02-01)
Objective: To determine correlations between age and metabolic disorders in Parkinson's disease (PD) patients. Methods: This observational cross-sectional study included brief tests for dementia and the Mattis test. Signals ...
Aspectos da deglutição conforme o tipo e o grau da demência
(Florianópolis, SC, 2020)
Metabolic syndrome and dementia associated with Parkinson's disease: impact of age and hypertension
(Assoc Arquivos Neuro- Psiquiatria, 2014)
Interação entre o peptídeo beta-amilóide (25-35) e a proteína alfa-sinucleína: implicações na neuropatogênese da doença de parkinson
(Universidade Federal do Rio de JaneiroBrasilInstituto de QuímicaUFRJ, 2019)